Korean J Obstet Gynecol.  2002 Jun;45(6):1033-1039.

Immunohistochemical Study on the Expression of Thymidine Phosphorylase and Ki-67 in the Uterine Cervical Neoplasia

• Jun S
• Han HS
• Kim CJ
• Bae DH
• Kim MK

Abstract

OBJECTIVE
We evaluated the relationship between the expression of Ki-67 and thymidine-phosphorylase (TP) according to the cancerous progression of uterine cervical cancer with immunohistochemical method.
METHODS
The material was obtained from hysterectomized uterus and punched cervical specimen for two years from 1998 to 1999 at the Soonchunhyang Chunan hospital. The material included 15 normal epithelium, 13 CIN I/II, 21 CIN III, 15 microinvasive carcinoma and 13 invasive carcinoma. Monoclonal antibodies of Ki-67 and TP were used for immunohistochemical determination of cellular proliferation and angiogenic activity.
RESULTS
1. The positive rate of thymidine phosphorylase in each group of normal epithelium, CIN I/II, CIN III, microinvasive carcinoma and invasive carcinoma were 6.7%, 23.1%, 38.0%, 73.3%, 84.6% respectively. 2. The labeling indexes of Ki-67 in each group of normal epithelium. CIN I/II, CIN III, microinvasive carcinoma and invasive carcinoma were 2.0+/-0.7, 26+/-5.4, 41.2+/-10.1, 74.7+/-9.3 respectively. 3. There was statistically significant relationship between TP and Ki-67 expression.
CONCLUSION
The above results indicates that the angiogenic activities and cellular proliferation indices increase according to the invasiveness of cervical cancer. We were able to reveal the expression of TP and Ki-67 and their relationship in cervical carcinoma.

Keyword

Thymidine phosphorylase; Ki-67; Uterine cervical neoplasia

MeSH Terms

Antibodies, Monoclonal
Cell Proliferation
Chungcheongnam-do
Epithelium
Thymidine Phosphorylase*
Thymidine*
Uterine Cervical Neoplasms
Uterus
Antibodies, Monoclonal
Thymidine
Thymidine Phosphorylase